Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Optimizing the doses of cancer drugs after usual dose finding.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Optimizing the doses of cancer drugs after usual dose finding.
Optimizing the doses of cancer drugs after usual dose finding. Clin Trials. 2024 Jun; 21(3):340-349.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials as Topic
Dose-Response Relationship, Drug
Humans
Maximum Tolerated Dose
Neoplasms
Research Design
authors with profiles
Mark J. Ratain
Walter M. Stadler